The safety of low dose aspirin in chronic kidney disease patients
碩士 === 國立成功大學 === 臨床藥學研究所 === 96 === Background: Chronic kidney disease (CKD) is becoming a worldwide health problem and the prevalence and incidence are growing fast. CKD is associated with an increased risk of adverse cardiovascular outcomes and is considered a cardiovascular disease (CVD) risk eq...
Main Authors: | Hsuan-ting Teng, 鄧軒婷 |
---|---|
Other Authors: | Jui-Chen Tsai |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/73945093344302458235 |
Similar Items
-
Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.
by: Ae Jin Kim, et al.
Published: (2014-01-01) -
Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study
by: Yun Jung Oh, et al.
Published: (2021-03-01) -
Safety of low-dose aspirin in endovascular treatment for intracranial atherosclerotic stenosis.
by: Ning Ma, et al.
Published: (2014-01-01) -
Prophylactic add-on antiplatelet therapy in chronic kidney disease with type 2 diabetes mellitus: Comparison between clopidogrel and low-dose aspirin
by: Amitabh Dash, et al.
Published: (2013-01-01) -
Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin
by: Ioannis Kariotis, et al.
Published: (2010-06-01)